Catalyst Pharmaceuticals ...

NASDAQ: CPRX · Real-Time Price · USD
20.06
-0.01 (-0.05%)
At close: Aug 15, 2025, 1:29 PM

Catalyst Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
491.73M 398.2M 214.2M 140.83M
Cost of Revenue
68.84M 84.53M 34.39M 21.88M
Gross Profit
422.89M 313.67M 179.81M 118.95M
Operating Income
195.12M 86.81M 101.84M 52.38M
Interest Income
n/a n/a n/a 282K
Pretax Income
216.26M 94.51M 104.72M 52.67M
Net Income
163.89M 71.41M 83.08M 39.48M
Selling & General & Admin
177.74M 133.71M 58.18M 49.63M
Research & Development
12.65M 93.15M 19.79M 16.94M
Other Expenses
37.38M n/a n/a 282K
Operating Expenses
227.76M 259.43M 77.97M 66.56M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
10M 86.69M 29.47M 26.15M
Cost & Expenses
296.61M 311.39M 112.36M 88.45M
Income Tax Expense
52.37M 23.1M 21.64M 13.19M
Shares Outstanding (Basic)
118.46M 106.28M 103.37M 103.38M
Shares Outstanding (Diluted)
124.94M 113.75M 111.38M 107.8M
EPS (Basic)
1.38 0.67 0.80 0.38
EPS (Diluted)
1.31 0.63 0.75 0.37
EBITDA
232.9M 119.69M 101.84M 52.38M
EBIT
195.12M 86.81M 104.72M 52.67M
Depreciation & Amortization
37.77M 32.88M 1.49M 484K